SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-07-045655
Filing Date
2007-08-21
Accepted
2007-08-21 19:27:24
Documents
1
Period of Report
2007-08-17

Document Format Files

Seq Description Document Type Size
1 v085871_ex.html 4  
1 v085871_ex.xml 4 2943
  Complete submission text file 0001144204-07-045655.txt   4890
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 HARBOUR SQUARE TORONTO ONTARIO CANA A1 M5J2G2
Business Address C/O GENEREX BIOTECHNOLOGY CORP 33 HARBOUR SQUARE TORONTO ONTARIO CANA A1 M5J2G2 4163642551
FLETCHER MARK (Reporting) CIK: 0001229529 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 071071898